Streetbeat News

Equity Actions

OKE

ONEOK Inc. (NYSE:OKE) stock is currently priced at $66.70, experiencing a slight decrease of 0.31%. Despite this, the stock has seen an increase of 0.51% over the past month and 1.90% over the past year. ONEOK's P/E ratio of 12.3 is lower than the industry average of 17.06, which could suggest that the stock is undervalued or that it may have weaker growth prospects compared to its industry peers.

Portfolio Pulse from Benzinga Insights

November 23, 2023 | 2:45 pm

DIA

IWM

QQQ

SPY

The U.S. stock market, including NYSE and Nasdaq, will be closed on Thanksgiving Day, Nov. 23, 2023, and will close early on Black Friday, Nov. 25, 2023. Major U.S. equity ETFs like QQQ, SPY, DIA, and IWM have shown varied performance year-to-date. Historically, Thanksgiving week sees thinner trading volumes but can lead to a 'Thanksgiving Rally' with the S&P 500 averaging a 0.54% increase in the past 50 years. Post-Thanksgiving, market focus will shift to retail data from Black Friday and Cyber Monday sales.

Portfolio Pulse from Piero Cingari

November 23, 2023 | 1:21 pm

ARKK

ARKW

DKNG

EXAS

GBTC

ROKU

TDOC

Ark Invest, led by Cathie Wood, purchased $12.6 million worth of Zoom Video Communications (ZM) shares after the company reported positive earnings, surpassing expectations. The shares were bought through ARK Innovation ETF (ARKK) and ARK Next Generation Internet ETF (ARKW). Ark Invest also increased its stake in Teladoc Inc (TDOC), sold shares of Exact Sciences Corp (EXAS), Draftkings Inc (DKNG), Roku Inc (ROKU), and Grayscale Bitcoin Investment Trust (GBTC).

Portfolio Pulse from Benzinga Neuro

November 23, 2023 | 2:17 am

BGXX

Bright Green Corporation (NASDAQ:BGXX) reported its Q3 2023 financial results with no revenues, reduced operating expenses from $5.8 million in Q3 2022 to $1.8 million, and a net loss of $1.9 million, which was in line with expectations. The company, under executive chairman Terry Rafih, is a DEA-registered entity for cannabis research and pharmaceutical purposes. It appointed Groovy Singh as CEO, executed an EB-5 capital raising program, and settled $3.6 million in debt with shares and warrants. BGXX also applied for regulatory approval to produce additional controlled substances and joined the Russell 3000 Index in June 2023. The stock traded down at $0.2878 per share, a 3.10% decrease.

Portfolio Pulse from Joana Scopel

November 22, 2023 | 10:57 pm

HOLI

Hollysys Automation Technologies plans to hold a special meeting of shareholders in January 2024. The company's special committee is expediting the sale process, indicating potential changes in ownership or structure.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 10:01 pm

RTX

Raytheon Technologies (RTX) has appointed Fredric Reynolds as its Lead Independent Director, effective December 1, 2023. Dinesh Paliwal will step down from the board on the same date. This change in board composition could influence the company's strategic decisions and oversight.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 9:32 pm

BRLI

Brilliant Acquisition Corporation has extended its deadline to complete a business combination until December 23, 2023. This extension provides additional time for the blank check company to find a suitable merger or acquisition target.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 9:18 pm

NMFC

New Mountain Finance Corporation (NMFC) has appointed Kris Corbett as its Chief Financial Officer (CFO), effective November 27. This change in the company's financial leadership could signal a strategic shift or a continuation of its current financial policies.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 9:15 pm

GII

IFRA

IGF

PAVE

TOLZ

President Joe Biden, trailing Donald Trump in 2024 election polls, is advised by Democratic experts to focus on infrastructure and social security to win. The Bipartisan Infrastructure Law, with $1.2 trillion investment in U.S. infrastructure, is highlighted as a key achievement. House Democrats are strategizing on messaging this success. Infrastructure ETFs like PAVE, IGF, IFRA, GII, and TOLZ could benefit from increased focus on infrastructure spending. Social security is also suggested as a critical issue for Biden to address, with potential plans to expand benefits.

Portfolio Pulse from Chris Katje

November 22, 2023 | 8:54 pm

GSK

GSK Inc. (NYSE:GSK) shares are trading at $35.23, down 0.44% in the current session. Over the past month, the stock has decreased by 2.29%, but it has increased by 3.63% over the past year. GSK's P/E ratio of 9.55 is lower than the Pharmaceuticals industry average of 38.89, which could suggest it is undervalued or that shareholders have lower growth expectations. Investors are advised to consider the P/E ratio alongside other financial metrics and qualitative analysis for a comprehensive investment decision.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 8:45 pm